12.20.2022
Therapeutics
$474,279.00
30 months
Interrogating the mechanism of hypersensitivity to antibody-based drugs for development of a novel anti-TNF biologic for Crohn's disease
This project aims to identify the regions of the anti-TNF molecule that activate the immune system, allowing for the design of potential new anti-TNF drugs that will maintain their effectiveness over time.